Invention Grant
- Patent Title: Methods for dosing an orally active 1,2,4-oxadiazole
- Patent Title (中): 口服有效的1,2,4-恶二唑的给药方法
-
Application No.: US11974068Application Date: 2007-10-11
-
Publication No.: US09226919B2Publication Date: 2016-01-05
- Inventor: Samit Hirawat , Langdon Miller
- Applicant: Samit Hirawat , Langdon Miller
- Applicant Address: US NJ South Plainfield
- Assignee: PTC Therapeutics, Inc.
- Current Assignee: PTC Therapeutics, Inc.
- Current Assignee Address: US NJ South Plainfield
- Agency: Jones Day
- Main IPC: A61K31/4245
- IPC: A61K31/4245
Abstract:
The present invention relates to specific doses of and dosing regimens for using a 1,2,4-oxadiazole benzoic acid compound in treating or preventing diseases associated with nonsense mutations. In particular, the invention relates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseases associated with nonsense mutations.
Public/Granted literature
- US20080114039A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy Public/Granted day:2008-05-15
Information query
